Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein

Nature Methods

Volumn 4, Issue 8, 2007, Pages 645-650

  Atarashi, Ryuichiro ^a   Moore, Roger A ^a   Sim, Valerie L ^a   Hughson, Andrew G ^a   Dorward, David W ^a   Onwubiko, Henry A ^a   Priola, Suzette A ^a   Caughey, Byron ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEINASE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; HAMSTER; INFRARED SPECTROSCOPY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SCRAPIE; SENSITIVITY ANALYSIS;

ANIMALS; BLOTTING, WESTERN; CEREBROSPINAL FLUID; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYDROLYSIS; MICE; MICROSCOPY, ELECTRON; PRPSC PROTEINS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

CRICETINAE; SCRAPIE PRION;

EID: 34547638271     PISSN: 15487091     EISSN: 15491676     Source Type: Journal    
DOI: 10.1038/nmeth1066     Document Type: Article

References (28)

1. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. US 95, 13363-13383 (1998).
2. Caughey, B. & Baron, G.S. Prions and their partners in crime. Nature 443, 803-810 (2006).
3. Silveira, J.R., Caughey, B. & Baron, G.S. Prion protein and the molecular features of transmissible spongiform encephalopathy agents. Curr. Top. Microbiol. Immunol. 284, 1-50 (2004).
4. Kocisko, D.A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994).
5. Saborio, G.P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (2001).
6. Castilla, J., Saa, P., Hetz, C. & Soto, C. In vitro generation of infectious scrapie prions. Cell 121, 195-206 (2005).
7. Deleault, N.R. et al. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. USA 104, 9741-9746 (2007).
8. Iniguez, V., McKenzie, D., Mirwald, J. & Aiken, J. Strain-specific propagation of PrP(Sc) properties into baculovirus-expressed hamster PrP(C). J. Gen. Virol. 81, 2565-2571 (2000).
9. Kirby, L., Birkett, C.R., Rudyk, H., Gilbert, I.H. & Hope, J. In vitro cell-free conversion of bacterial recombinant PrP to PrPres as a model for conversion. J. Gen. Virol. 84, 1013-1020 (2003).
10. Eiden, M. et al. Synergistic and strain-specific effects of bovine spongiform encephalopathy and scrapie prions in the cell-free conversion of recombinant prion protein. J. Gen. Virol. 87, 3753-3761 (2006).
11. Surewicz, W.K., Jones, E.M. & Apetri, A.C. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro. Acc. Chem. Res. 39, 654-662 (2006).
12. Baskakov, I.V. & Breydo, L. Converting the prion protein: What makes the protein infectious. Biochim. Biophys. Acta 1772, 692-703 (2007).
13. Legname G. et al. Synthetic mammalian prions. Science 305 673-676 (2004).
14. Saa, P., Castilla, J. & Soto, C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 28, 35245-35252 (2006).
15. Saa, P., Castilla, J. & Soto, C. Presymptomatic detection of prions in blood Science 313, 92-94 (2006).
16. Raymond, G.J. & Chabry, J. Purification of the pathological isoform of prion protein (PrPSc or PrPres) from transmissible spongiform encephalopathy-affected brain tissue in Techniques in Prion Research (eds., Lehmann, S. & Grassi, J.) 16-26 (Birkhauser Verlag, Basel, 2004).
17. Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743 (2001).
18. Silveira, J.R. et al. The most infectious prion protein particles. Nature 437, 257-261 (2005).
19. Caughey, B. et al. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds? Act. Chem. Res. 39, 646-653 (2006).
20. Trevitt, C.R. & Collinge, J. A systematic review of prion therapeutics in experimental models. Brain 129, 2241-2265 (2006).
21. Pan, K.-M. et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion protein. Proc. Natl. Acad. Sci. USA 90, 10962-10966 (1993).
22. Homemann, S., Schom, C. & Wuthrich, K. NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep. 5, 1159-1164 (2004).
23. Caughey, B., Raymond, G.J. & Bessen, R.A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 273, 32230-32235 (1998).
24. Caughey, B.W. et al. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680 (1991).
25. Xiong, L.W., Raymond, L.D., Hayes, S.F., Raymond, G.J. & Caughey, B. Conformational. change, aggregation and fibril formation induced by detergent treatments of cellular prion protein. J. Neurachem. 79, 669-678 (2001).
26. Bocharova, O.V. et al. Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. J. Biol. Chem. 281, 2373-2379 (2006).
27. Zahn, R., von Schroetter, C. & Wuthrich, K. Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett. 417, 400-404 (1997).
28. Caughey, B., Raymond, G.J., Emst, D. & Race, R.E. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65, 6597-6603 (1991).